| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.021 | 0.7 |